Compositions and methods for viral sensitization

Patent metadata

Field	Value
Publication number	US-10654839-B2
Application number	US-201615546167-A
Country	US
Kind code	B2
Filing date	Jan 26, 2016
Priority date	Jan 26, 2015
Publication date	May 19, 2020
Grant date	May 19, 2020

Abstract

Provided are compounds of Formula (II) that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.
Compounds of Formula (II):

First claim

What is claimed is:

1. A method for enhancing or increasing viral production in cells comprising administering a compound of Formula (II):

or a pharmaceutically acceptable salt, or stereochemically isomeric form thereof, wherein:
X 1 is substituted N;
X 2 is halogen or NHX 3 , wherein X 3 is a substituted or unsubstituted, linear or branched alkyl, alkenyl, or alkynyl; or substituted or unsubstituted aryl or heteroaryl;
i is 0;
- - - is absent when i is 0 such that X 1 is directly bonded to the X 4 -bearing carbon through a single bond; and
X 4 is OH;
to said cells prior to, after or concurrently with a virus, and culturing the virus and cells.

2. The method of claim 1 , wherein the cells are cultured cells, adherent or suspension cells, cancer cells, tumor cells or cells which have been immortalized, primary cells, non-immortalized cells, normal cells, eggs, or egg cells contained within or derived from embryonated eggs.

3. The method of claim 2 , wherein the cells are cancer cells or non-cancer cells in vitro or in ovo.

4. The method of claim 1 , wherein enhancing or increasing viral production comprises one or more of enhancing or increasing the infection of cells or a rate thereof, enhancing or increasing reproductive capacity of a virus or a rate thereof, enhancing or increasing spread or titer of a virus or a rate at which full titer may be reached, enhancing or increasing antigen expression from a virus or a rate thereof, enhancing or increasing gene or transgene expression from a virus or a rate thereof, or enhancing or increasing virus protein expression in cells or a rate thereof, or any combination thereof.

5. The method of claim 1 , wherein X 2 is halogen.

6. The method of claim 5 , wherein X 2 is Cl.

7. The method of claim 1 , wherein the compound is of Formula (III):

wherein X 5 is substituted or unsubstituted, linear or branched C 1 -C 12 alkyl, alkenyl, or alkynyl; substituted or unsubstituted alkynyloxy; substituted or unsubstituted mono- or bi-cycloaryl or -heteroaryl; substituted or unsubstituted mono- or bi-cycloalkyl; or substituted or unsubstituted mono- or bi-heterocycloalkyl.

8. The method of claim 7 , wherein X 5 is phenyl, alkylphenyl, substituted phenyl, benzyl, substituted benzyl, triazolyl, substituted triazolyl, naphthalenyl, substituted naphthalenyl, substituted or unsubstituted pyridinyl, substituted or unsubstituted furanyl; substituted or unsubstituted thiofuranyl, thiophenyl, sulfonobenzyl, methylsulfonobenzyl, pyrrolyl, substituted or unsubstituted morpholine, cycloalkyl, alkylthiol, substituted or unsubstituted alkylamine, or substituted or unsubstituted oxazoline.

9. The method of claim 7 , wherein X 5 is substituted or unsubstituted, linear C 1 -C 12 alkyl.

10. The method of claim 8 , wherein X 5 is benzyl or substituted benzyl.

11. The method of claim 1 , wherein the compound is of formula (VII):

wherein X 9 is OH.

12. The method of claim 4 , wherein enhancing or increasing viral production comprises one or more of enhancing or increasing the infection of cells or a rate thereof.

13. The method of claim 4 , wherein enhancing or increasing viral production comprises one or more of enhancing or increasing reproductive capacity of a virus or a rate thereof.

Assignees

• Ottawa Hospital Res Inst
• Univ Ottawa

Inventors

• Diallo Jean-Simon
• Boddy Christopher Noyce
• Dornan Mark
• Krishnan Ramya
• Arulanandam Rozanne
• Le Boeuf Fabrice
• Smith Jeffrey
• Macklin Andrew

Classifications

• C07D209/48

  with oxygen atoms in positions 1 and 3, e.g. phthalimide · CPC title

• C07D471/04

  Ortho-condensed systems · CPC title

• C12N2760/20252

  relating to complementing cells and packaging systems for producing virus or viral particles · CPC title

• C07D237/14

  Oxygen atoms · CPC title

• A61P35/02

  specific for leukemia · CPC title